ArticleAutophagy2023

Genome-Scale CRISPR screen identifies LAPTM5 driving lenvatinib resistance in hepatocellular carcinoma.

Jiaomeng Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.